Neurocritical Care

, Volume 1, Issue 4, pp 479–488 | Cite as

Coagulopathy in traumatic brain injury

New Presepectives In Management Of Brain Injury

Abstract

Abnormalities in blood coagulation, although quite common after traumatic brain injury (TBI), are of unknown significance. The authors review the clinical and pathophysiological features of this phenomenon and emphasize its origin in disseminated intravascular coagulation. This connection provides a possible explanation for much of the cerebral ischema that accompanies TBI, namely intravascular microthrombosis. The authors’ own research findings support this contention and suggest possible therapeutic avenues.

A number of compelling studies demonstrate that DIC is a common and important consequence of TBI. In particular, posttraumatic coagulapathy appears to be linked to secondary cerebral injury. Although the extent of this process has yet to be elucidated fully, coagulation abnormalities are evident soon after trauma. This allows early identification of patients likely to suffer secondary complications and provides an opportunity to evaluate promising agents that may mitigate posttraumatic DIC and related pathologies in these patients. This is an area deserving of more intensive research.

Key Words

Traumatic brain injury coagulopathy disseminated intravascular coagulation cerebral ischemia intravascular microthrombosis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Penick GD, McLendon WW. Disorders of the hemostatic mechanism. Int Rev Med 1960;173:491–496.Google Scholar
  2. 2.
    Attar S, Boyd D, Layne E, McLaughlin J, Mansberger AR, Cowley RA. Alterations in coagulation and fibrinolytic mechanisms in acute trauma. J Trauma 1969;9:939–965.PubMedGoogle Scholar
  3. 3.
    MacGee EE, Bernell WR. Acute fibrinolysis following craniotomy and removal of metastatic tumor of the cerebellum. Case report. J Neurosurg 1970;32:578–580.PubMedGoogle Scholar
  4. 4.
    Druskin MS, Drijansky R. Afibrinogenemia with severe head trauma. JAMA 1972;219:755,756.PubMedCrossRefGoogle Scholar
  5. 5.
    Vecht CJ, Sibinga CT, Minderhoud JM. Disseminated intravascular coagulation and head injury. J Neurol Neurosurg Psychiatry 1975;38:567–571.PubMedGoogle Scholar
  6. 6.
    Vecht CJ, Minderhoud JM, Sibinga CT. Platelet aggregability in relation to impaired consciousness after head injury. J Clin Pathol 1975;28:814–820.PubMedCrossRefGoogle Scholar
  7. 7.
    Goodnight SH. Defibrination following head injury. Compr Ther 1977;3:25–28.PubMedGoogle Scholar
  8. 8.
    van der Sande JJ, Veltkamp JJ, Boekhout-Mussert RJ, Bouwhuis-Hoogerwerf ML. Head injury and coagulation disorders. J Neurosurg 1978;49:357–365.PubMedGoogle Scholar
  9. 9.
    Auer L. Disturbances of the coagulatory system in patients with severe cerebral trauma. I. Acta Neurochir (Wien) 1978;43:51–59.CrossRefGoogle Scholar
  10. 10.
    Auer LM, Ott E. Disturbances of the coagulatory system in patients with severe cerebral trauma II. Platelet function. Acta Neurochir (Wien) 1979;49:219–226.CrossRefGoogle Scholar
  11. 11.
    Sawada Y, Sadamitsu D, Sakamoto T, Ikemura K, Yoshioka T, Sugimoto T. Lack of correlation between delayed traumatic intracerebral haematoma and disseminated intravascular coagulation. J Neurol Neurosurg Psychiatry 1984;47:1125–1127.PubMedGoogle Scholar
  12. 12.
    Kaufman HH, Mattson JC. Coagulopathy in head injury. In: Central Nervous System Trauma Status Report. (Becker DP, Povlishock JT, ed.). National Institute of Neurological and Communicative Disorders and Stroke. Bethesda, MD, 1985, 187–206.Google Scholar
  13. 13.
    Touho H, Hirakawa K, Hino A, Karasawa J, Ohno Y. Relationship between abnormalities of coagulation and fibrinolysis and postoperative intracranial hemorrhage in head injury. Neurosurgery 1986;19:523–531.PubMedCrossRefGoogle Scholar
  14. 14.
    Cortiana M, Zagara G, Fava S, Seveso M. Coagulation abnormalities in patients with head injury. J Neurosurg Sci 1986;30:133–138.PubMedGoogle Scholar
  15. 15.
    Olson JD, Kaufman HH, Moake J, et al. The incidence and significance of hemostatic abnormalities in patients with head injuries. Neurosurgery 1989;24:825–832.PubMedCrossRefGoogle Scholar
  16. 16.
    Piek J, Chesnut RM, Marshall LF, et al. Extracranial complications of severe head injury. J Neurosurg 1992;77:901–907.PubMedGoogle Scholar
  17. 17.
    Stein SC, Young GS, Talucci RC, Greenbaum BH, Ross SE. Delayed brain injury after head trauma: significance of coagulopathy. Neurosurgery 1992;30:160–165.PubMedCrossRefGoogle Scholar
  18. 18.
    Sorensen JV, Jensen HP, Rahr HB, et al. Haemostatic activation in patients with head injury with and without simultaneous multiple trauma. Scand J Clin Lab Invest 1993;53:659–665.PubMedGoogle Scholar
  19. 19.
    Bredbacka S, Edner G. Soluble fibrin and d-dimer as detectors of hypercoagulability in patients with isolated brain trauma. J Neurosurg Anesthesiol 1994;6:75–82.PubMedGoogle Scholar
  20. 20.
    Selladurai BM, Vickneswaran M, Duraisamy S, Atan M. Coagulopathy in acute head injury—a study of its role as a prognostic indicator. Br J Neurosurg 1997;11:398–404.PubMedCrossRefGoogle Scholar
  21. 21.
    May AK, Young JS, Butler K, Bassam D, Brady W. Coagulopathy in severe closed head injury: is empiric therapy warranted? Am Surg 1997;63:233–236; discussion 236,237.PubMedGoogle Scholar
  22. 22.
    Scherer RU, Spangenberg P. Procoagulant activity in patients with isolated severe head trauma. Crit Care Med 1998;26:149–156.PubMedCrossRefGoogle Scholar
  23. 23.
    Gando S, Nanzaki S, Kemmotsu O. Coagulofibrinolytic changes after isolated head injury are not different from those in trauma patients without head injury. J Trauma 1999;46:1070–1076; discussion 1076,1077.PubMedGoogle Scholar
  24. 24.
    Jacoby RC, Owings JT, Holmes J, Battistella FD, Gosselin RC, Paglieroni TG. Platelet activation and function after trauma. J Trauma 2001;51:639–647.PubMedGoogle Scholar
  25. 25.
    Kushimoto S, Yamamoto Y, Shibata Y, Sato H, Koido Y. Implications of excessive fibrinolysis and alpha2-plasmin inhibitor deficiency in patients with severe head injury. Neurosurgery 2001;49:1084–1090.PubMedCrossRefGoogle Scholar
  26. 26.
    Murshid WR, Gader AG. The coagulopathy in acute head injury: comparison of cerebral versus peripheral measurements of haemostatic activation markers. Br J Neurosurg 2002;16:362–369.PubMedCrossRefGoogle Scholar
  27. 27.
    Pondaag W. Disseminated intravascular coagulation related to outcome in head injury. Acta Neurochir Suppl 1979;28:98–102.Google Scholar
  28. 28.
    Hoots WK, Contant C, Mattson J, et al. The “talk and die” phenomenon: disseminated intravascular coagulation as a possible explanation for dramatic deterioration among head trauma patients. Blood 1983;62(Suppl 1):1003.Google Scholar
  29. 29.
    Stein SC, Spettell C, Young G, Ross SE. Delayed and progressive brain injury in closed-head trauma: radiological demonstration. Neurosurgery 1993;32:25–30;discussion 30,31.PubMedCrossRefGoogle Scholar
  30. 30.
    Stein SC, Spettell CM. Delayed and progressive brain injury in children and adolescents with head trauma. Pediatr Neurosurg 1995;23:299–304.PubMedCrossRefGoogle Scholar
  31. 31.
    Kearney TJ, Bentt L, Grode M, Lee S, Hiatt JR, Shabot MM. Coagulopathy and catecholamines in severe head injury. J Trauma 1992;32:608–611;discussion 611,612.PubMedGoogle Scholar
  32. 32.
    Gando S, Nakanishi Y, Tedo I. Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome. Crit Care Med 1995;23:1835–1842.PubMedCrossRefGoogle Scholar
  33. 33.
    Becker S, Schneider W, Kreuz W, Jacobi G, Scharrer I, Nowak-Gottl U. Post-trauma coagulation and fibrinolysis in children suffering from severe cerebro-cranial trauma. Eur J Pediatr 1999;158 Suppl 3:S197–202.PubMedCrossRefGoogle Scholar
  34. 34.
    Vavilala MS, Dunbar PJ, Rivara FP, Lam AM. Coagulopathy predicts poor outcome following head injury in children less than 16 years of age. J Neurosurg Anesthesiol 2001;13:13–18.PubMedCrossRefGoogle Scholar
  35. 35.
    Hoots WK. Coagulation Disorders in the Head-Injured Patient. In: Neurotrauma. (Narayan RKWJ, Povlishock JT, eds.). McGraw-Hill, New York, 1996,673–688.Google Scholar
  36. 36.
    Astrup T. Assay and content of tissue thromboplastin in different organs. Thromb Diath Haemorrh 1965;14:401–416.PubMedGoogle Scholar
  37. 37.
    Keimowitz RM, Annis BL. Disseminated intravascular coagulation associated with massive brain injury. J Neurosurg 1973;39:178–180.PubMedGoogle Scholar
  38. 38.
    Goodnight SH, Kenoyer G, Rapaport SI, Patch MJ, Lee JA, Kurze T. Defibrination after brain-tissue destruction: a serious complication of head injury. N Engl J Med 1974;290:1043–1047.PubMedCrossRefGoogle Scholar
  39. 39.
    Quick AJ. Determination of prothrombin. Proc Soc Exp Biol Med 1939;42:788,789.Google Scholar
  40. 40.
    Edwards RL, Rickles FR. The role of leukocytes in the activation of blood coagulation. Semin Hematol 1992;29:202–212.PubMedGoogle Scholar
  41. 41.
    Johnson K, Aarden L, Choi Y, De Groot E, Creasey A. The proinflammatory cytokine response to coagulation and endotoxin in whole blood. Blood 1996;87:5051–5060.PubMedGoogle Scholar
  42. 42.
    Johnson K, Choi Y, DeGroot E, Samuels I, Creasey A, Aarden L. Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation. J Immunol 1998;160:5130–5135.PubMedGoogle Scholar
  43. 43.
    Esmon CT. Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis. Baillieres Best Pract Res Clin Haematol 1999;12:343–359.PubMedCrossRefGoogle Scholar
  44. 44.
    van der Pool T, de Jonge E, Levi M. Regulatory role of cytokines indisseminated intravascular coagulation. Semin Thromb Hemost 2001;27:639–651.CrossRefGoogle Scholar
  45. 45.
    Joseph L, Fink LM, Hauer-Jensen M. Cytokines in coagulation and thrombosis: a preclinical and clinical review. Blood Coagul Fibrinolysis 2002;13:105–116.PubMedCrossRefGoogle Scholar
  46. 46.
    Miller DL, Welty-Wolf K, Carraway MS, et al. Extrinsic coagulation blockade attenuates lung injury and proinflammatory cytokine release after intratracheal lipopolysaccharide. Am J Respir Cell Mol Biol 2002;26:650–658.PubMedGoogle Scholar
  47. 47.
    Bonnemaison J, Thicoipe M, Dixmerias F, Guerin V. [-Coagulopathy suggestive of a primary fibrinolysis after head injuries with brain death]. Ann Fr Anesth Reanim 1998;17:275–277.PubMedGoogle Scholar
  48. 48.
    Churliaev IA, Lychev VG, Epifantseva NN, Afanas’ev AG. [Clinicopathogenetic variants of DIC syndrome in patients with severe craniocerebral trauma]. Anesteziol Reanimatol 1999:35–37.Google Scholar
  49. 49.
    Taylor FB, Jr., Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001;86:1327–1330.PubMedGoogle Scholar
  50. 50.
    Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999;341:586–592.PubMedCrossRefGoogle Scholar
  51. 51.
    Kushimoto S, Shibata Y, Yamamoto Y. Implications of fibrinogenolysis in patients with closed head injury. J Neurotrauma 2003;20:357–363.PubMedCrossRefGoogle Scholar
  52. 52.
    Yokota H, Naoe Y, Nakabayashi M, et al. Cerebral endothelial injury in severe head injury: the significance of measurements of serum thrombomodulin and the von Willebrand factor. J Neurotrauma 2002;19:1007–1015.PubMedCrossRefGoogle Scholar
  53. 53.
    Kaufman HH, Moake JL, Olson JD, et al. Delayed and recurrent intracranial hematomas related to disseminated intravascular clotting and fibrinolysis in head injury. Neurosurgery 1980;7:445–449.PubMedCrossRefGoogle Scholar
  54. 54.
    Ninchoji T, Uemura K, Shimoyama I, Hinokuma K, Bun T, Nakajima S. Traumatic intracerebral haematomas of delayed onset. Acta Neurochir 1984;71:69–90.CrossRefGoogle Scholar
  55. 55.
    Bullock R, Hanemann CO, Murray L, Teasdale GM. Recurrent hematomas following craniotomy for traumatic intracranial mass. J Neurosurg 1990;72:9–14.PubMedGoogle Scholar
  56. 56.
    Mellion BT, Narayan RK. Delayed traumatic intracerebral hematomas and coagulopathies. In: Complications and Sequelae of Head Injury. (Barrow DL, ed.). American Association of Neurological Surgeons, Park Ridge, IL, 1992, 51–59.Google Scholar
  57. 57.
    Resnick DK, Marion DW, Darby JM. The effect of hypothermia on the incidence of delayed traumatic intracerebral hemorrhage. Neurosurgery 1994;34:252–255;discussion 255,256.PubMedCrossRefGoogle Scholar
  58. 58.
    Oertel M, Kelly DF, McArthur D, et al. Progressive hemorrhage after head trauma: predictors and consequences of the evolving injury. J Neurosurg 2002;96:109–116.PubMedGoogle Scholar
  59. 59.
    Graham DI, Adams JH. Ischaemic brain damage in fatal head injuries. Lancet 1971;1:265,266.PubMedCrossRefGoogle Scholar
  60. 60.
    Graham DI, Ford I, Adams JH, et al. Ischaemic brain damage is still common in fatal non-missile head injury. J Neurol Neurosurg Psychiatry 1989;52:346–350.PubMedGoogle Scholar
  61. 61.
    Teasdale GM, Graham DI. Craniocerebral trauma: protection and retrieval of the neuronal population after injury. Neurosurgery 1998;43:723–737.PubMedCrossRefGoogle Scholar
  62. 62.
    Kaufman HH, Hui KS, Mattson JC, et al. Clinicopathological correlations of disseminated intravascular coagulation in patients with head injury. Neurosurgery 1984;15:34–42.PubMedCrossRefGoogle Scholar
  63. 63.
    Preston FE, Malia RG, Sworn MJ, Timperley WR, Blackburn EK. Disseminated intravascular coagulation as a consequence of cerebral damage. J Neurol Neurosurg Psychiatry 1974;37:241–248.PubMedGoogle Scholar
  64. 64.
    Coccheri S, Tests C. Regional intravascular coagulation and micro thrombosis in traumatic brain lacerations in man. In: Aggregation in the Pathogenesis of Cerebrovascular Disorders. (Agnoti A FC, ed.). Springer-Verlag, Berlin, 1977,121–128.Google Scholar
  65. 65.
    Watts C. Disseminated intravascular coagulation. Surg Neurol 1977;8:258–262.PubMedGoogle Scholar
  66. 66.
    Huber A, Dorn A, Witzmann A, Cervos-Navarro J. Microthrombi formation after severe head trauma. Int J Legal Med 1993;106:152–155.PubMedCrossRefGoogle Scholar
  67. 67.
    Lafuente JV, Cervos-Navarro J. Craniocerebral trauma induces hemorheological disturbances. J Neurotrauma 1999;16:425–430.PubMedGoogle Scholar
  68. 68.
    van der Sande JJ, Emeis JJ, Lindeman J. Intravascular coagulation: a common phenomenon in minor experimental head injury. J Neurosurg 1981;54:21–25.PubMedGoogle Scholar
  69. 69.
    Cortez SC, McIntosh TK, Noble LJ. Experimental fluid percussion brain injury: vascular disruption and neuronal and glial alterations. Brain Res 1989;482:271–282.PubMedCrossRefGoogle Scholar
  70. 70.
    Dietrich WD, Alonso O, Halley M. Early microvascular and neuronal consequences of traumatic brain injury: a light and electron microscopic study in rats. J Neurotrauma 1994;11:289–301.PubMedCrossRefGoogle Scholar
  71. 71.
    Dietrich WD, Alonso O, Busto R, et al. Widespread hemodynamic depression and focal platelet accumulation after fluid percussion brain injury: a double-label autoradiographic study in rats. J Cereb Blood Flow Metab 1996;16:481–489.PubMedCrossRefGoogle Scholar
  72. 72.
    Maeda T, Katayama Y, Kawamata T, Aoyama N, Mori T. Hemodynamic depression and microthrombosis in the peripheral areas of cortical contusion in the rat: role of platelet activating factor. Acta Neurochir Suppl 1997;70:102–105.PubMedGoogle Scholar
  73. 73.
    Daneyemez M. Microangiographic changes following cerebral contusion in rats. Neuroscience 1999;92:783–790.PubMedCrossRefGoogle Scholar
  74. 74.
    Liu AY, Maldjian JA, Bagley LJ, Sinson GP, Grossman RI. Traumatic brain injury: diffusion-weighted MR imaging findings. AJNR Am J Neuroradiol 1999;20:1636–1641.PubMedGoogle Scholar
  75. 75.
    Stein SC, Chen X-H, Sinson GP, Smith DH. Intravascular coagulation: a major secondary insult in nonfatal traumatic brain injury. J Neurosurg 2002;97:1373–1377.PubMedGoogle Scholar
  76. 76.
    Nicoll JA, Roberts GW, Graham DI. Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury. Nat Med 1995;1:135–137.PubMedCrossRefGoogle Scholar
  77. 77.
    Auer RN, Benveneste H. Hypoxia and related conditions. In: Greenfield’s Neuropathology. (Graham DI, Lantos PL, eds.). Arnold, London, 1997,263–314.Google Scholar
  78. 78.
    Stein SC, Graham DI, Chen XH, Smith DH. Association between intravascular microthrombosis and cerebral ischemia in traumatic brain injury. Neurosurgery 2004;54:687–691.PubMedCrossRefGoogle Scholar
  79. 79.
    Pasaoglu H, Inci Karakucuk E, Kurtsoy A, Pasaoglu A. Endogenous neuropeptides in patients with acute traumatic head injury, I: cerebrospinal fluid beta-endorphin levels are increased within 24 hours following the trauma. Neuropeptides 1996;30:47–51.PubMedCrossRefGoogle Scholar
  80. 80.
    Holmin S, Soderlund J, Biberfeld P, Mathiesen T. Intracerebral inflammation after human brain contusion. Neurosurgery 1998;42:291–298.PubMedCrossRefGoogle Scholar
  81. 81.
    Kalabalikis P, Papazoglou K, Gouriotis D, et al. Correlation between serum IL-6 and CRP levels and severity of head injury in children. Intensive Care Med 1999;25:288–292.PubMedCrossRefGoogle Scholar
  82. 82.
    Malham GM, Souter MJ. Systemic inflammatory response syndrome and acute neurological disease. Br J Neurosurg 2001;15:381–387.PubMedCrossRefGoogle Scholar
  83. 83.
    Lee KR, Betz AL, Kim S, Keep RF, Hoff JT. The role of the coagulation cascade in brain edema formation after intracerebral hemorrhage. Acta Neurochir 1996;138:396–400.CrossRefGoogle Scholar
  84. 84.
    Lee KR, Colon GP, Betz AL, Keep RF, Kim S, Hoff JT. Edema from intracerebral hemorrhage: the role of thrombin. J Neurosurg 1996;84:91–96.PubMedCrossRefGoogle Scholar
  85. 85.
    Gong C, Boulis N, Qian J, Turner DE, Hoff JT, Keep RF. Intracerebral hemorrhage-induced neuronal death. Neurosurgery 2001;48:875–882;discussion 882,883.PubMedCrossRefGoogle Scholar
  86. 86.
    Xi G, Reiser G, Keep RF. The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective? J Neurochem 2003;84:3–9.PubMedCrossRefGoogle Scholar
  87. 87.
    Fakhry SM, Rutherford EJ, G.F. S. Hematologic Principles in Surgery. In: Sabiston Textbook of Surgery. (Townsend CMJ, Beauchamp RD, Evers BM, Mattox KL, eds.). W. B. Saunders Company, Philadelphia, 2001,83,84.Google Scholar
  88. 88.
    Aleksandrov VN, Zverev VV, Karmolina LF, Budiakova GN. [Clotting properties of the blood in severe craniocerebral injuries]. Zh Vopr Neirokhir Im N N Burdenko 1984:19–23.Google Scholar
  89. 89.
    Kaufmann CR, Dwyer KM, Crews JD, Dols SJ, Trask AL. Usefulness of thrombelastography in assessment of trauma patient coagulation. J Trauma 1997;42:716–720;discussion 720–722 Russian.PubMedGoogle Scholar
  90. 90.
    Ungerstedt JS, Grenander A, Bredbacka S, Blomback M. Clotting onset time may be a predictor of outcome in human brain injury: a pilot study. J Neurosurg Anesthesiol 2003;15:13–18.PubMedCrossRefGoogle Scholar
  91. 91.
    Abrahams JM, Torchia MB, McGarvey M, Putt M, Baranov D, Sinson GP. Perioperative assessment of coagulability in neurosurgical patients using thromboelastography. Surg Neurol 2002;58:5–11;discussion 11,12.PubMedCrossRefGoogle Scholar
  92. 92.
    Hoots WK. Experience with antithrombin concentrates in neurotrauma patients. Semin Thromb Hemost 1997;23:3–16.PubMedGoogle Scholar
  93. 93.
    Owings JT, Bagley M, Gosselin R, Romac D, Disbrow E. Effect of critical injury on plasma antithrombin activity: low antithrombin levels are associated with thromboembolic complications. J Trauma 1996;41:396–405;discussion 405,406.PubMedGoogle Scholar
  94. 94.
    Owings JT, Gosselin R. Acquired antithrombin deficiency following severe traumatic injury: rationale for study of antithrombin supplementation. Semin Thromb Hemost 1997;23:17–24.PubMedGoogle Scholar
  95. 95.
    Grenander A, Bredbacka S, Rydvall A, et al. Antithrombin treatment in patients with traumatic brain injury: a pilot study. J Neurosurg Anesthesiol 2001;13:49–56.PubMedCrossRefGoogle Scholar
  96. 96.
    Emerson TE, Jr., Fournel MA, Redens TB, Taylor FB, Jr. Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia. Am J Med 1989;87:27S-33S.PubMedCrossRefGoogle Scholar
  97. 97.
    Penner J, Francis C, Hassouna H, et al. Roundtable discussion and preliminary guidelines for clinical studies involving antithrombin concentrate and trauma patients. Semin Thromb Hemost 1997;23 Suppl 1:25–29.Google Scholar
  98. 98.
    Warren BL, Eid A, Singer P, et al. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 2001;286:1869–1878.PubMedCrossRefGoogle Scholar
  99. 99.
    Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699–709.PubMedCrossRefGoogle Scholar
  100. 100.
    Shibata M, Kumar SR, Amar A, et al. Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke. Circulation 2001;103:1799–1805.PubMedGoogle Scholar
  101. 101.
    Khouri RK, Koudsi B, Kaiding F, Ornberg RL, Wun TC. Prevention of thrombosis by topical application of tissue factor pathway inhibitor in a rabbit model of vascular trauma. Ann Plast Surg 1993;30:398–402;discussion 402–404.PubMedCrossRefGoogle Scholar
  102. 102.
    Lantieri LA, Ozbek MR, Deune EG, et al. Prevention of microvascular thrombosis by topical application of recombinant tissue factor pathway inhibitor. Plast Reconstr Surg 1996;97:587–594.PubMedCrossRefGoogle Scholar
  103. 103.
    Lee WL, Downey GP. Coagulation inhibitors in sepsis and disseminated intravascular coagulation. Intensive Care Med 2000;26:1701–1706.PubMedCrossRefGoogle Scholar
  104. 104.
    Levi M, de Jonge E, van der Poll T, ten Cate H. Novel approaches to the management of disseminated intravascular coagulation. Crit Care Med 2000;28:S20-S24.PubMedCrossRefGoogle Scholar
  105. 105.
    de Jonge E, Dekkers PE, creasey AA, et al. Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia. Blood 2000;95:1124–9.PubMedGoogle Scholar
  106. 106.
    Kubo Y, Suzuki M, Kudo A, et al. Thrombin inhibitor ameliorates secondary damage in rat brain injury: suppression of inflammatory cells and vimentin-positive astrocytes. J Neurotrauma 2000;17:163–172.PubMedGoogle Scholar
  107. 107.
    Kitaoka T, Hua Y, Xi G, Hoff JT, Keep RF. Delayed argatroban treatment reduces edema in a rat model of intracerebral hemorrhage. Stroke 2002;33:3012–3018.PubMedCrossRefGoogle Scholar
  108. 108.
    Zhang ZG, Zhang L, Tsang W, et al. Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion. Brain Res 2001;912:181–194.PubMedCrossRefGoogle Scholar
  109. 109.
    Wang X, Xu L, Wang H, et al. Inhibition of factor Xa reduces ischemic brain damage after thromboembolic stroke in rats. Stroke 2003;34:468–474.PubMedCrossRefGoogle Scholar
  110. 110.
    Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med 2003;31:S213-S220.PubMedCrossRefGoogle Scholar
  111. 111.
    Ruf W, Riewald M. Tissue factor-dependent coagulation protease signaling in acute lung injury. Crit Care Med 2003;31:S231-S237.PubMedCrossRefGoogle Scholar
  112. 112.
    Russell JA. Genetics of coagulation factors in acute lung injury. Crit Care Med 2003;31:S243-S247.PubMedCrossRefGoogle Scholar
  113. 113.
    Laterre PF, Wittebole X, Dhainaut JF. Anticoagulant therapy in acute lung injury. Crit Care Med 2003;31:S329-S336.PubMedCrossRefGoogle Scholar
  114. 114.
    Yang Y, Li Q, Nakada MT, Yang T, Shuaib A. Angiographic evaluation of middle cerebral artery reperfusion caused by platelet glycoprotein IIb/IIIa receptor complex antagonist murine 7E3 F(ab′)2 in a model of focal cerebral ischemia in rats. J Neurosurg 2001;94:582–588.PubMedGoogle Scholar
  115. 115.
    Buchanan DC, Kochanek PM, Nemoto EM, Melick JA, Schoettle RJ. Platelet-activating factor receptor blockade decreases early posttraumatic cerebral edema. Ann NY Acad Sci 1989;559:427,428.CrossRefGoogle Scholar
  116. 116.
    Faden AI, Tzendzalian PA. Platelet-activating factor antagonists limit glycine changes and behavioral deficits after brain trauma. Am J Physiol 1992;263:R909-R914.PubMedGoogle Scholar
  117. 117.
    Bentzer P, Mattiasson G, McIntosh TK, Wieloch T, Grande PO. Infusion of prostacyclin following experimental brain injury in the rat reduces cortical lesion volume. J Neurotrauma 2001;18:275–285.PubMedCrossRefGoogle Scholar
  118. 118.
    Grande PO, Moller AD, Nordstrom CH, Ungerstedt U. Low-dose prostacyclin in treatment of severe brain trauma evaluated with microdialysis and jugular bulb oxygen measurements. Acta Anaesthesiol Scand 2000;44:886–894.PubMedCrossRefGoogle Scholar
  119. 119.
    Naredi S, Olivecrona M, Lindgren C, Ostlund AL, Grande PO, Koskinen LO. An outcome study of severe traumatic head injury using the “Lund therapy” with low-dose prostacyclin. Acta Anaesthesiol Scand 2001;45:402–406.PubMedCrossRefGoogle Scholar
  120. 120.
    Wahl F, Grosjean-Piot O, Bareyre F, Uzan A, Stutzmann JM. Enoxaparin reduces brain edema, cerebral lesions, and improves motor and cognitive impairments induced by a traumatic brain injury in rats. J Neurotrauma 2000;17:1055–1065.PubMedGoogle Scholar
  121. 121.
    Iizuka H, Kadoya S, Suzuki T, Shimazaki K. [Low-dose intravenous heparin therapy for disseminated intravascular coagulation following head injury: case report]. No Shinkei Geka 1983;11:765–769 Japanese.PubMedGoogle Scholar
  122. 122.
    Iizuka H, Kadoya S, Kwak R, Suzuki T, Sato S. [Disseminated intravascular coagulation following severe head injury. Role of low dose heparin]. Neurol Med Chir (Tokyo) 1984;24:696–700 Japanese.Google Scholar
  123. 123.
    Wojcik R, Cipolle MD, Seislove E, Wasser TE, Pasquale MD. Preinjury warfarin does not impact outcome in trauma patients. J Trauma 2001;51:1147–1151; discussion 1151,1152.PubMedGoogle Scholar
  124. 124.
    Alberts MJ. tPA in acute ischemic stroke: United States experience and issues for the future. Neurology 1998;51:S53-S55.PubMedGoogle Scholar
  125. 125.
    Koennecke HC, Nohr R, Leistner S, Marx P. Intravenous tPA for ischemic stroke team performance over time, safety, and efficacy in a single-center, 2-year experience. Stroke 2001;32:1074–1078.PubMedGoogle Scholar
  126. 126.
    Schellinger PD, Fiebach JB, Mohr A, Ringleb PA, Jansen O, Hacke W. Thrombolytic therapy for ischemic stroke—a review. Part II—ilntra-arterial thrombolysis, vertebrobasilar stroke, phase IV trials, and stroke imaging. Crit Care Med 2001;29:1819–1825.PubMedCrossRefGoogle Scholar
  127. 127.
    Schellinger PD, Fiebach JB, Mohr A, Ringleb PA, Jansen O, Hacke W. Thrombolytic therapy for ischemic stroke—a review. Part I—intravenous thrombolysis. Crit Care Med 2001;29:1812–1818.PubMedCrossRefGoogle Scholar
  128. 128.
    Furlan AJ, Abou-Chebi A. The role of recombinant pro-urokinase (r-pro-UK) and intra-arterial thrombolysis in acute ischaemic stroke: the PROACT trials. Prolyse in Acute Cerebral Thromboembolism. Curr Med Res Opin 2002;18:s44-s47.PubMedCrossRefGoogle Scholar
  129. 129.
    Lee DH, Jo KD, Kim HG, et al. Local intraarterial urokinase thrombolysis of acute ischemic stroke with or without intravenous abciximab: a pilot study. J Vasc Interv Radiol 2002;13:769–774.PubMedCrossRefGoogle Scholar
  130. 130.
    Hardaway RM. The etiology and treatment of traumatic and septic shock. Compr Ther 1999;25:330–334.PubMedGoogle Scholar
  131. 131.
    Pechlaner C. Plasminogen activators in inflammation and sepsis. Acta Med Austriaca 2002;29:80–88.PubMedCrossRefGoogle Scholar
  132. 132.
    Lapchak PA, Araujo DM, Pakola S, Song D, Wei J, Zivin JA. Microplasmin: a novel thrombolytic that improves behavioral outcome after embolic strokes in rabbits. Stroke 2002;33:2279–2284.PubMedCrossRefGoogle Scholar
  133. 133.
    Tsirka SE, Bugge TH, Degen JL, Strickland S. Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin. Proc Natl Acad Sci USA 1997;94:9779–9781.PubMedCrossRefGoogle Scholar
  134. 134.
    Grabb PA. Traumatic intraventricular hemorrhage treated with intraventricular recombinant-tissue plasminogen activator: technical case report. Neurosurgery 1998;43:966–969.PubMedCrossRefGoogle Scholar
  135. 135.
    Lucas CE, Ledgerwood AM, Saxe JM, Dombi G, Lucas WF. Plasma supplementation is beneficial for coagulation during severe hemorrhagic shock. Am J Surg 1996;171:399–404.PubMedCrossRefGoogle Scholar
  136. 136.
    Mueller M, Bomke B, Seifried E. Fresh frozen plasma in patients with disseminated intravascular coagulation or in patients with liver diseases. Thromb Res 2002;107 Suppl 1:S9.Google Scholar
  137. 137.
    Winter JP, Plummer D, Bottini A, Rockswold GR, Ray D. Early fresh frozen plasma prophylaxis of abnormal coagulation parameters in the severely head-injured patient is not effective. Ann Emerg Med 1989;18:553–555.PubMedCrossRefGoogle Scholar
  138. 138.
    Palmer JD, Francis JL, Pickard JD, Ianotti F. The efficacy and safety of aprontin for hemostasis during intracranial surgery. J Neurosurg 2003;98:1208–1216.PubMedGoogle Scholar
  139. 139.
    Vivien D, Buisson A. Serine protease inhibitors: novel therapeutic targets for stroke? J Cereb Blood Flow Metab 2000;20:755–764.PubMedCrossRefGoogle Scholar
  140. 140.
    Roos YB, Vermeulen M, Rinkel GJ, Algra A, Van Gijn J. Systematic review of antifibrinolytic treatment in aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 1998;65:942,943.PubMedGoogle Scholar
  141. 141.
    Roberts HR. Recombinant factor VIIa (Novoseven) and the safety of treatment. Semin Hematol 2001;38:48–50.PubMedCrossRefGoogle Scholar
  142. 142.
    Hedner U. Recombinant factor VIIa (NovoSeven) as a hemostatic agent. Dis Mon 2003;49:39–48.PubMedGoogle Scholar
  143. 143.
    Aldouri M. The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients. Pathophysiol Haemost Thromb 2002;32:41–46.PubMedCrossRefGoogle Scholar
  144. 144.
    Argall J, Teece S. Towards evidence based emergency medicine: best BETs from Manchester Royal Infirmary. Factor VIIa for intractable blood loss in trauma. Emerg Med J 2002;19:556,557.PubMedCrossRefGoogle Scholar
  145. 145.
    Jeroukhimov I, Jewelewicz D, Zaias J, et al. Early injection of high-dose recombinant factor VIIa decreases blood loss and prolongs time from injury to death in experimental liver injury. J Trauma 2002;53:1053–1057.PubMedGoogle Scholar
  146. 146.
    Schreiber MA, Holcomb JB, Hedner U, Brundage SI, Macaitis JM, Hoots K. The effect of recombinant factor VIIa on coagulopathic pigs with grade V liver injuries. J Trauma 2002;53:252–257; discussion 257–259.PubMedGoogle Scholar
  147. 147.
    Rice KM, Savidge GF. NovoSeven (recombinant factor VIIa) in central nervous systems bleeds. Haemostasis 1996;26:131–134.PubMedGoogle Scholar
  148. 148.
    Lusher J, Ingerslev J, Roberts H, Hedner U. Clinical experience with recombinant factor VIIa. Blood Coagul Fibrinolysis 1998;9:119–128.PubMedCrossRefGoogle Scholar
  149. 149.
    Hedner U, Ingerslev J. Clinical use of recombinant FVIIa (rFVIIa). Transfus Sci 1998;19:163–176.PubMedCrossRefGoogle Scholar
  150. 150.
    Arkin S, Cooper HA, Hutter JJ, et al. Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors. Results of the novoseven emergency-use program. Haemostasis 1998;28:93–98.PubMedCrossRefGoogle Scholar
  151. 151.
    Veshchev I, Elran H, Salame K. Recombinant Coagulation Factor VIIa for rapid preoperative correction of Warfarin-related coagulopathy in patients with acute subdural hematoma. Med Sci Monit 2002;8:CS98-CS100.PubMedGoogle Scholar
  152. 152.
    Lin J, Hanigan WC, Tarantino M, Wang J. The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings. J Neurosurg 2003;98:737–740.PubMedGoogle Scholar
  153. 153.
    Morenski JD, Tobias JD, Jimenez DF. Recombinant activated factor VII for cerebral injury-induced coagulopathy in pediatric patients. Report of three cases and review of the literature. J Neurosurg 2003;98:611–616.PubMedGoogle Scholar
  154. 154.
    Park P, Fewel ME, Thompson BG, Hoff JT. Recombinant activated factor VII for the rapid correction of coagulopathy in non-hemophilic neurosurgical patients. Neurosurgery 2003;53:34–38;discussion 38,39.PubMedCrossRefGoogle Scholar
  155. 155.
    Haj-Yehia A, Nassar T, Sachais BS, et al. Urokinase-derived peptides regulate vascular smooth muscle contraction in vitro and in vivo. Faseb J 2000;14:1411–1422.PubMedCrossRefGoogle Scholar
  156. 156.
    Guo Y, Higazi AA, Arakelian A, et al. A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo. Faseb J 2000;14:1400–1410.PubMedCrossRefGoogle Scholar
  157. 157.
    Kataoka K, Asai T, Taneda M, et al. Roles of urokinase type plasminogen activator in a brain stab wound. Brain Res 2000;887:187–190.PubMedCrossRefGoogle Scholar
  158. 158.
    Mori T, Wang X, Kline AE, et al. Reduced cortical injury and edema in tissue plasminogen activator knockout mice after brain trauma. Neuroreport 2001;12:4117–4120.PubMedCrossRefGoogle Scholar
  159. 159.
    Hall ED. Beneficial effects of acute intravenous ibuprofen on neurologic recovery of head-injured mice: comparison of cyclooxygenase inhibition with inhibition of thromboxane A2 synthetase or 5-lipoxygenase. Cent Nerv Syst Trauma 1985;2:75–83.PubMedGoogle Scholar
  160. 160.
    Hurley SD, Olschowka JA, O’Banion MK. Cyclooxygenase inhibition as a strategy to ameliorate brain injury. J Neurotrauma 2002;19:1–15.PubMedCrossRefGoogle Scholar
  161. 161.
    Markgraf CG, Clifton GL, Moody MR. Treatment window for hypothermia in brain injury. J Neurosurg 2001;95:979–983.PubMedGoogle Scholar
  162. 162.
    Mori K, Miyazaki M, Iwase H, Maeda M. Temporal profile of changes in brain tissue extracellular space and extracellular ion (Na(+), K(+)) concentrations after cerebral ischemia and the effects of mild cerebral hypothermia. J Neurotrauma 2002;19:1261–1270.PubMedCrossRefGoogle Scholar
  163. 163.
    Polderman KH, Tjong Tjin Joe R, Peerdeman SM, Vandertop WP, Girbes AR. Effects of therapeutic hypothermia on intracranial pressure and outcome in patients with severe head injury. Intensive Care Med 2002;28:1563–1573.PubMedCrossRefGoogle Scholar
  164. 164.
    Saatman KE, Bareyre FM, Grady MS, McIntosh TK. Acute cytoskeletal alterations and cell death induced by experimental brain injury are attenuated by magnesium treatment and exacerbated by magnesium deficiency. J Neuropathol Exp Neurol 2001;60:183–194.PubMedGoogle Scholar
  165. 165.
    Ustun ME, Duman A, Ogun CO, Vatansev H, Ak A. Effects of nimodipine and magnesium sulfate on endogenous antioxidant levels in brain tissue after experimental head trauma. J Neurosurg Anesthesiol 2001;13:227–232.PubMedCrossRefGoogle Scholar
  166. 166.
    FitzGerald GA. Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists. Am J Cardiol 1991;68:11B-15B.PubMedCrossRefGoogle Scholar
  167. 167.
    Fuentes A, Rojas A, Porter KB, Saviello G, O’Brien WF. The effect of magnesium sulfate on bleeding time in pregnancy. Am J Obstet Gynecol 1995;173:1246–1249.PubMedCrossRefGoogle Scholar
  168. 168.
    Lenting PJ, Christophe OD, Maat H, Rees DJ, Mertens K. Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding. J Biol Chem 1996;271:25,332–25,337.Google Scholar
  169. 169.
    Watts DD, Trask A, Soeken K, Perdue P, Dols S, Kaufmann C. Hypothermic coagulopathy in trauma: effect of varying levels of hypothermia on enzyme speed, platelet function, and fibrinolytic activity. J Trauma 1998;44:846–854.PubMedCrossRefGoogle Scholar
  170. 170.
    Ravn HB. Pharmacological effects of magnesium on arterial thrombosis—mechanisms of action? Magnes Res 1999;12:191–199.PubMedGoogle Scholar
  171. 171.
    Aibiki M, Maekawa S, Yokono S. Moderate hypothermia improves imbalances of thromboxane A2 and prostaglandin I2 production after traumatic brain injury in humans. Crit Care Med 2000;28:3902–3906.PubMedCrossRefGoogle Scholar
  172. 172.
    Kmiecik SA, Liu JL, Vaadia TS, et al. Quantitative evaluation of hypothermia, hyperthermia, and hemodilution on coagulation. J Extra Corpor Technol 2001;33:100–105.PubMedGoogle Scholar
  173. 173.
    Weiss HJ. Antiplatelet Therapy. In: Williams Hematology. (Beutler E, Coller BS, Lichtman MA, Kipps TJ, Seligsohn U, eds.). McGraw-Hill, New York, 2001.Google Scholar

Copyright information

© Humana Press Inc 2004

Authors and Affiliations

  1. 1.Department of NeurosurgeryUniversity of Pennsylvania School of MedicinePhiladelphia

Personalised recommendations